Restenosis: a challenge for pharmacology
- 1 July 2000
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 21 (7) , 274-279
- https://doi.org/10.1016/s0165-6147(00)01505-4
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Continuous Perivascularl-Arginine Delivery Increases Total Vessel Area and Reduces Neointimal Thickening After Experimental Balloon DilatationArteriosclerosis, Thrombosis, and Vascular Biology, 1999
- Gene Transfer of Human Prostacyclin Synthase Prevents Neointimal Formation After Carotid Balloon Injury in RatsStroke, 1999
- Vascular Gene TransferArteriosclerosis, Thrombosis, and Vascular Biology, 1999
- Endothelin and restenosisCardiovascular Research, 1998
- Direct evidence for the importance of endothelium-derived nitric oxide in vascular remodeling.Journal of Clinical Investigation, 1998
- VEGF Gene Transfer Reduces Intimal Thickening via Increased Production of Nitric Oxide in Carotid ArteriesHuman Gene Therapy, 1997
- Fibrin(ogen) and von Willebrand Factor Deposition Are Associated With Intimal Thickening After Balloon Angioplasty of the Rabbit Carotid ArteryArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- Arterial Gene Therapy for Restenosis. St. Elizabeth's Medical Center, Tufts University School of Medicine, Boston, MassachusettsHuman Gene Therapy, 1996
- Taxol inhibits neointimal smooth muscle cell accumulation after angioplasty in the rat.Journal of Clinical Investigation, 1995
- Randomised trial of coronary intervention with antibody against platelet IIb/IIIa iritegrin for reduction of clinical restenosis: results at six monthsThe Lancet, 1994